REFERENCES
1. Tripathi M, Singh BK, Zhou J, et al. Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation. J Hepatol 2022;77:1246-55.
2. Åberg F, Jula A, Lundqvist A, Männistö V. Hyperhomocysteinemia predicts liver-related clinical outcomes in the general population. J Hepatol 2023;78:e172-4.
3. Xu R, Huang F, Wang Y, Liu Q, Lv Y, Zhang Q. Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. Sci Rep 2020;10:17401.
4. Zhu Z, Jiang S, Li C, Liu J, Tao M. Relationship between serum homocysteine and different menopausal stage. Climacteric 2020;23:59-64.
5. Sadre-Marandi F, Dahdoul T, Reed MC, Nijhout HF. Sex differences in hepatic one-carbon metabolism. BMC Syst Biol 2018;12:89.
6. Morris MS, Jacques PF, Selhub J, Rosenberg IH. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000;152:140-8.
7. Kim R, Nijhout HF, Reed MC. One-carbon metabolism during the menstrual cycle and pregnancy. PLoS Comput Biol 2021;17:e1009708.
8. Moylan CA, Pang H, Dellinger A, et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 2014;59:471-82.
9. Kleiner DE, Brunt EM, Van Natta M, et al; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
10. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 2000;130:377S-81S.
11. Barathi S, Angayarkanni N, Pasupathi A, et al. Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy. Diabetes Care 2010;33:2031-7.
12. Perła-Kaján J, Borowczyk K, Głowacki R, Nygård O, Jakubowski H. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans. FASEB J 2018;32:6019-24.
13. Liu YQ, Jia Z, Han F, et al. Suppression effects of betaine-enriched spinach on hyperhomocysteinemia induced by guanidinoacetic acid and choline deficiency in rats. ScientificWorldJournal 2014;2014:904501.
14. Fischer LM, daCosta KA, Kwock L, et al. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr 2007;85:1275-85.
15. Kobayashi T, Kessoku T, Ozaki A, et al. Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial. J Clin Biochem Nutr 2021;68:181-6.
16. Bombardieri G, Pappalardo G, Bernardi L, Barra D, Di Palma A, Castrini G. Intestinal absorption of S-adenosyl-L-methionine in humans. Int J Clin Pharmacol Ther Toxicol 1983;21:186-8.
17. Jung SB, Nagaraja V, Kapur A, Eslick GD. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis. Intern Med J 2015;45:409-16.
18. Liu Q, Li S, Quan H, Li J. Vitamin B12 status in metformin treated patients: systematic review. PLoS One 2014;9:e100379.
19. De Vincentis A, Mancina RM, Pihlajamäki J, et al. Genetic variants in the MTHFR are not associated with fatty liver disease. Liver Int 2020;40:1934-40.
20. Chen P, Yang Z, Guo L, Huang Y, Li J, Chen X. Effects of homocysteine on nonalcoholic fatty liver related disease: a mendelian randomization study. Front Mol Biosci 2022;9:1083855.
21. Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 2019;70:1457-69.
